Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Aclaris Therapeutics, Inc. ACRS

Set alert

Price alert · ACRS

All alert types
3.80 USD -0.17 -4.28%

At close · Nov 2

3.80 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
3.78 × 2
Ask
3.79 × 2
3.77 Day range 4.04
2.13 52-week range 6.53
YTD
+26.25%
1 year
+50.79%
Open
4.09
Prev close
3.97
Mkt cap
588.94M
Vol
1.64M
Avg vol
2.91M
EPS
-0.55
P/E
0.00
Div yield
0.00%
More statistics
Low
3.77
High
4.04
Forward P/E
-5.00
Beta
0.12
Short ratio
0.47
Inst. own
90.21%
Dividend
0.00
Ex-div date
50-d avg
2.70
200-d avg
1.58
1y target
10.00

5D chart

Chart tools
Interval
1m5m15m30m

Signals (76)
NameTimeAgo
SMA: BearishOct 30, 3:55 PM3 days ago
SMA: BullishOct 30, 3:50 PM3 days ago
MACD: Buy SignalOct 30, 3:35 PM3 days ago
SMA: BullishOct 30, 3:30 PM3 days ago
SMA: BearishOct 30, 2:10 PM3 days ago
MACD: Sell SignalOct 30, 1:30 PM3 days ago
SMA: BullishOct 30, 1:15 PM3 days ago
MACD: Buy SignalOct 30, 1:15 PM3 days ago
MACD: Sell SignalOct 30, 1:10 PM3 days ago
SMA: BullishOct 30, 11:55 AM3 days ago
MACD: Buy SignalOct 30, 11:55 AM3 days ago
MACD: Sell SignalOct 30, 11:45 AM3 days ago
SMA: BearishOct 30, 11:25 AM3 days ago
MACD: Buy SignalOct 30, 10:45 AM3 days ago
SMA: BullishOct 30, 10:35 AM3 days ago
SMA: BearishOct 30, 9:45 AM3 days ago
MACD: Sell SignalOct 30, 9:45 AM3 days ago
MACD: Buy SignalOct 29, 3:10 PM4 days ago
MACD: Sell SignalOct 29, 1:50 PM4 days ago
SMA: BullishOct 29, 1:15 PM4 days ago

Newest 20 of 76.

Analyst view

Consensus: buy

Buy
Price target (mean) 10.00 +163.2% upside
Target (low)
5.00
Target (mean)
10.00
Target (high)
20.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 7
  • 2 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ACRS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.324-0.54 – -0.10-0.02-1520.0%6.25M-64.4%5
Next quarter-0.21-0.21 – -0.21-0.24+12.5%2.58M+7.7%1
Current year-0.864-1.13 – -0.58-1.27+32.0%15.75M-49.6%5
Next year-0.52-0.59 – -0.45-0.864+39.8%11.98M-23.9%4

Upgrades and downgrades

The latest rating changes

ACRS analyst upgrades and downgrades
DateFirmActionFromTo
Dec 23, 2024HC Wainwright & Co.UpgradeNeutralBuy
Nov 19, 2024Leerink PartnersUpgradeMarket PerformOutperform
Nov 19, 2024JefferiesUpgradeHoldBuy
Nov 19, 2024BTIGUpgradeNeutralBuy
Nov 18, 2024Piper SandlerUpgradeNeutralOverweight
Sep 17, 2024HC Wainwright & Co.Reiterated—Neutral
Aug 19, 2024HC Wainwright & Co.Reiterated—Neutral
Jul 22, 2024HC Wainwright & Co.Reiterated—Neutral
Jan 22, 2024HC Wainwright & Co.DowngradeBuyNeutral
Jan 11, 2024BTIGDowngradeBuyNeutral
Dec 29, 2023HC Wainwright & Co.ReiteratedBuyBuy
Dec 18, 2023StifelMaintainedHoldHold
Nov 14, 2023HC Wainwright & Co.MaintainedBuyBuy
Nov 14, 2023Cantor FitzgeraldDowngradeOverweightNeutral
Nov 13, 2023StifelDowngradeBuyHold
Nov 13, 2023William BlairDowngradeOutperformMarket Perform
Oct 9, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Oct 4, 2023HC Wainwright & Co.ReiteratedBuyBuy
Oct 3, 2023Evercore ISI GroupInitiated—Outperform
Sep 19, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Sep 19, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 14, 2023StifelMaintainedBuyBuy
Aug 8, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 14, 2023HC Wainwright & Co.ReiteratedBuyBuy
Mar 7, 2023Goldman SachsMaintained—Buy
Mar 7, 2023BTIGMaintained—Buy
Mar 7, 2023HC Wainwright & Co.Maintained—Buy
Feb 24, 2023HC Wainwright & Co.Reiterated—Buy
Feb 7, 2023Cantor FitzgeraldReiterated—Overweight
Dec 14, 2022StifelInitiated—Buy